REFERENCES
- Apostolou T, Gokal R. Quality of life after peritoneal dialysis. The Textbook of Peritoneal Dialysis, R Gokal, R Khanna, R Krediet, KD Nolph. Kluwer Academics, DordrechtThe Netherlands 2000; 709–735
- Fitzpatrick R, Fletcer A, Gore S, et al. Quality of life measures in health care, I: Application and issues in assessment. BMJ 1992; 305: 1074–1077
- Fitzpatrick R, Fletcer A, Gore S, et al. Quality of life measures in health care, II: Design, analysis, and interpretation. BMJ 1992; 305: 1145–1148
- Van-Dijk PCW, Jager KJ, de Charro F, et al. Registry report. Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant 2001; 16: 1120–1129
- [email protected], U.S. Renal Data System 2004 Annual Data Report: Incidence and prevalence of ESRD.
- Viglino G, Cancarini C, Catizone L, et al. Ten years experience of CAPD in diabetics: comparison of results with non-diabetics. Nephrol Dial Transplant 1994; 9: 1443–1448
- Balaskas EV, Yuan ZY, Gypta A, et al. Long-term CAPD in diabetics. Clin Nephrol 1994; 42(1)54–62
- Moreno F, Lopez Gomez JM, Sanz-Guajardo D, Jofre R, Valderrabano F, on behalf of the Spanish Cooperative Renal Patients Quality of Life Study Group. Quality of life in dialysis patients. A Spanish multicenter study. Nephrol Dial Transplant 1996; 11(Suppl. 2)125–129
- Gokal R. Quality of life in patients undergoing renal replacement therapy. Kidney Intern 1993; 43(Suppl. 40)S23–S27
- Gokal R, Figueras M, Olle A, Rovira J, Badia X. Outcomes in peritoneal dialysis and hemodialysis—a comparative assessment of survival and quality of life. Nephrol Dialysis Transplant 1999; 14(Suppl. 6)24–30
- Mingardi G, Cornalba L, Cortinovis E, Rugiata R, Mosconi P, Apolone G. Health-related quality of life in dialysis patients. A report from an Italian study using the SF-36 Health Survey. DIAQOL Group. Nephrol Dialysis Transplant 1999; 14(6)1503–1510
- Gill TM, Feinstein AR. A critical appraisal of the quality of life measurements. JAMA 1994; 272(8)619–625
- Tarlow AR, Ware JE, Greenfield S, Nelson EC, Pernn E, Jubkoff M. The MOS study: an application of methods for monitoring the results of medical care. JAMA 1989; 262: 925–930
- Ware JE, Sherbourne CD. The MOS 36 item short form health survey (SF-36) I. Conceptual framework and item selection. Med Care. 1992; 30: 473–483
- McHorney CA, Ware JE, Racjek AG. The MOS 36 item short form health survey. II. Psychometric and clinical tests of validity in measuring physical and medical health constructs. Med Care. 1993; 31: 247–263
- Salek MS, Reakes AM. Quality of life assessment in end-stage renal disease using a renal specific quality profile (RQLP): A practicality and validation study. Report I. University of Wales, Cardiff 1994
- Salek SM. Quality of life assessment in patients on peritoneal dialysis: A review of the state of the art. Perit Dial Int. 1996; 16(Suppl. 1)S398–S401
- Merkus MP, Jager KJ, Dekker FW, De Haan RJ, Boeschoten EW, Krediet RT. Quality of life over time in dialysis: the Netherlands Cooperative Study Group on the adequacy of dialysis. NECOSAD study group. Kidney Int. 1999; 56(2)720–728
- Wight JP, Edwards L, Brazier J, Walters S, Payne JN, Brown CB. The SF-36 as an outcome measure of services for end-stage renal failure. Qual Health Care 1998; 7(4)209–221
- Young MJ, Boulton AJM, MacLeod AF, et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150–154
- Young MJ, Jones GC. Diabetic neuropathy: Symptoms, signs and assessment. Diabetic Neuropathy, AJM Boulton. Marius Press, Carnforth, LancashireUK 1997; 41–61
- Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. An Int Med. 1993; 118: 622–629
- Tzamaloukas AH, Yuan ZY, Murata GH, Balaskas E, Avasthi PS, Oreopoulos DG. Clinical Associations of glycemic control in diabetics on CAPD. Adv Perit Dial 1993; 9: 291–294
- Prichard SS. Comorbidities and their impact on outcome in patients with end-stage renal disease. Kidney Intern 2000; 57: 100–104
- Jofre R, Lopez-Gomez JM, Valderrabano F. Quality of life for patient groups. Kidney Intern 2000; 57: 121–130
- Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Bole DH, Cruz I, Umana WQ, Alleyne S, Veis JH. Aspects of quality of life in HD patients. JASN 1995; 6(5)1418–1425
- Laupacis A, Keown P, Pus N, Krueger H, Ferguson B, Wong C, Muirhead N. A study of the quality of life and cost-utility of renal transplantation. Kidney Intern 1996; 50: 235–242
- Guyatt GH, Cook DJ. Commentary. Health status, quality of life, and the individual. JAMA 1994; 272(8)630–631